
Vaxcyte Stock Jumps 31% After Positive Phase 3 Data
Vaxcyte (PCVX) closed at $73.82 as its VAX-31 shot held up against Pfizer's and Merck's shots in a large trial
Daily Digest
Daily Digest
Pomegra Briefs - Page 23 of 52
Short, sourced summaries of the biggest market stories - what happened, why it matters, the key numbers, and what to watch next

Vaxcyte (PCVX) closed at $73.82 as its VAX-31 shot held up against Pfizer's and Merck's shots in a large trial
Accenture (ACN) slid to about $200 a day after its best session ever as investors locked in gains.
SpaceX (SPCX) traded up about 5% Monday on a Morgan Stanley note after its three-launch run.

Hewlett Packard Enterprise (HPE) landed a $1.2B AMD rack order, and Teradyne (TER) rose 8% on AI test tools
Vistra (VST) trades near $146 as the US plans a $4B loan to boost output at three nuclear plants.
RXO (RXO) agrees to a $5.8B cash-and-stock sale as C.H. Robinson (CHRW) shares drop 13% on dilution fears.

Schneider Electric (SU.PA) agreed to pay $205 a share in cash, a 42% premium, for US software maker PTC.
Saudi oil income is $60B a year above its pre-war level as Aramco (2222.SR) ships crude around Hormuz

Nikkei 225 (^N225) briefly topped 70,000 as soft US jobs data cut Fed hike odds and lifted chip stocks.

Brent crude (BZ=F) trades near $102 as 10,000 more US troops head to the Gulf ahead of possible Iran strikes

Reliance (RELIANCE.NS) unit Jio targets a $143B-plus value, with an Oct. 21 launch, mostly to repay debt.

Fair Isaac (FICO) is down more than 60% this year as regulators open mortgage scoring to rival VantageScore

iShares MSCI Brazil ETF (EWZ) rose to $42.12 from $38.19 as Bolsonaro led Lula 47% to 45%; runoff is Oct. 25.

Rocket Lab (RKLB) booked 20 Synspective launches; McCormick (MKC) also rose premarket on a Q3 beat.

Brent crude (BZ=F) ended Friday at $102.25 as the US rejected Iran's terms to reopen the Strait of Hormuz
Page 23 of 52 · 776 briefs